JIC
AGN

Joel Isaacson & Co’s Allergan plc AGN Stock Holding History

Joel Isaacson & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-366
Closed -$77K – 586
2016
Q4 		$77K Sell
366
-94
-20% -$19.5K 0.02% 254
2016
Q3 		$106K Sell
460
-78
-14% -$19.1K 0.02% 231
2016
Q2 		$124K Sell
538
-147
-21% -$33.9K 0.03% 209
2016
Q1 		$184K Buy
685
+335
+96% +$95.9K 0.04% 172
2015
Q4 		$109K Hold
350
– – 0.03% 214
2015
Q3 		$95K Sell
350
-37
-10% -$11.4K 0.03% 237
2015
Q2 		$117K Buy
387
+37
+11% +$11K 0.03% 230
2015
Q1 		$104K Hold
350
– – 0.03% 254
2014
Q4 		$90K Buy
+350
New +$87.5K 0.02% 248

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Joel Isaacson & Co's AGN Position: Q1 2017 in Review

Joel Isaacson & Co sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 366 shares — an estimated $77K sold.

Joel Isaacson & Co first reported a position in AGN in Q4 2014 and held it in 9 quarters. The position peaked at $184K in Q1 2016. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Joel Isaacson & Co reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Joel Isaacson & Co sold 366 Allergan plc shares in Q1 2017, an estimated $77K.
  • Joel Isaacson & Co first reported a position in Allergan plc in Q4 2014 and held it in 9 quarters.
  • Joel Isaacson & Co's Allergan plc position peaked at $184K in Q1 2016.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Joel Isaacson & Co's 13F filing for Q1 2017, filed 5 May 2017.